SignalsAIM
SEC Filing Analysis

AIM — Complete Signal History

Every significant change detected in AIM's SEC filings by Tracenotes — language shifts, financial anomalies, and risk signals across all analyzed 10-K and 10-Q filings.

1
Filings analyzed
1
High signals
0
Medium signals
0
Low signals
Signal Timeline
High10-KRisk

AIM has dramatically narrowed its strategic focus to solely pancreatic cancer while experiencing severe financial deterioration in...

2026-03-27
View →
Analyze Any Filing Free

See what changed in AIM's latest filing

50,000+ filings across the S&P 500. Instant language delta and financial analysis.

Analyze AIM free →
Other Companies Analyzed
TDUPOTGAWOTGAUWSTNUWSTNREMISRSVACWSVACU